ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » North Carolina » Pulmonary Disease

Top Pulmonary Disease Prescribers in North Carolina

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
EDWARD HAWKINS M.D.

Pulmonary Disease

29,873

$1.54M

1122
803 are 65+

8%
patients receiving schedule two controlled substances

Avg: 0%

23%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 57%

$51
Average prescription price

Avg: $178

BABYSAROJAH RAVINDRAN MD

Pulmonary Disease

9,921

$822K

539
392 are 65+

4%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 57%

$83
Average prescription price

Avg: $178

DANIEL GOTTOVI MD

Pulmonary Disease

8,672

$486K

316
196 are 65+

10%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 57%

$56
Average prescription price

Avg: $178

JEFFREY SILVER M.D.

Pulmonary Disease

8,430

$608K

523
383 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

36%
prescriptions for brand name drugs

Avg: 57%

$72
Average prescription price

Avg: $178

SOMNATH NAIK M.D.

Pulmonary Disease

7,507

$1.24M

505
354 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

49%
prescriptions for brand name drugs

Avg: 57%

$166
Average prescription price

Avg: $178

GREGORY UNDERWOOD MD

Pulmonary Disease

6,969

$515K

428
361 are 65+

4%
patients receiving schedule two controlled substances

Avg: 0%

7%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 57%

$74
Average prescription price

Avg: $178

GARY SCHAFER M.D

Pulmonary Disease

6,793

$704K

637
447 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

50%
prescriptions for brand name drugs

Avg: 57%

$104
Average prescription price

Avg: $178

THOMAS MURPHY M.D.

Pulmonary Disease

6,633

$444K

430
357 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 57%

$67
Average prescription price

Avg: $178

DAVID ZAAS M.D.

Pulmonary Disease

6,385

$1.45M

263
127 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 57%

$228
Average prescription price

Avg: $178

GIDEON BESSON MD

Pulmonary Disease

6,221

$458K

327
255 are 65+

4%
patients receiving schedule two controlled substances

Avg: 0%

14%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 57%

$74
Average prescription price

Avg: $178

AHMED ELNAGGAR M.D.

Pulmonary Disease

6,009

$726K

661
441 are 65+

2%
patients receiving schedule two controlled substances

Avg: 0%

10%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

40%
prescriptions for brand name drugs

Avg: 57%

$121
Average prescription price

Avg: $178

JAMES KELLING MD

Pulmonary Disease

4,588

$413K

439
346 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

39%
prescriptions for brand name drugs

Avg: 57%

$90
Average prescription price

Avg: $178

JAMES JONES M.D.

Pulmonary Disease

4,310

$606K

406
355 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

55%
prescriptions for brand name drugs

Avg: 57%

$141
Average prescription price

Avg: $178

ROBERT GALLAHER MD FCCP FACP

Pulmonary Disease

4,067

$1.02M

594
440 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

62%
prescriptions for brand name drugs

Avg: 57%

$251
Average prescription price

Avg: $178

FRANCIS COLLINS MD

Pulmonary Disease

4,013

$451K

404
347 are 65+

3%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

45%
prescriptions for brand name drugs

Avg: 57%

$112
Average prescription price

Avg: $178

RAMARAO SURESH M.D.

Pulmonary Disease

3,984

$790K

468
318 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

69%
prescriptions for brand name drugs

Avg: 57%

$198
Average prescription price

Avg: $178

ESTRELITA CLAVIO-ZIECHMANN MD

Pulmonary Disease

3,971

$638K

416
335 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

57%
prescriptions for brand name drugs

Avg: 57%

$161
Average prescription price

Avg: $178

BARRY COALSON MD

Pulmonary Disease

3,717

$358K

243
204 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

8%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

40%
prescriptions for brand name drugs

Avg: 57%

$96
Average prescription price

Avg: $178

HERBIE BRYAN MD

Pulmonary Disease

3,714

$565K

409
294 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

58%
prescriptions for brand name drugs

Avg: 57%

$152
Average prescription price

Avg: $178

NARAYANACHAR SEKARAN MD

Pulmonary Disease

3,620

$300K

572
379 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

38%
prescriptions for brand name drugs

Avg: 57%

$83
Average prescription price

Avg: $178

DONALD RABIL MD

Pulmonary Disease

3,601

$665K

413
329 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

75%
prescriptions for brand name drugs

Avg: 57%

$185
Average prescription price

Avg: $178

GAUTAM DEV MD

Pulmonary Disease

3,586

$536K

371
227 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

63%
prescriptions for brand name drugs

Avg: 57%

$149
Average prescription price

Avg: $178

JOHN REYNOLDS M.D.

Pulmonary Disease

3,534

$429K

198
99 are 65+

8%
patients receiving schedule two controlled substances

Avg: 0%

16%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 57%

$121
Average prescription price

Avg: $178

EMEKA EZIRI MD

Pulmonary Disease

3,507

$744K

434
247 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

73%
prescriptions for brand name drugs

Avg: 57%

$212
Average prescription price

Avg: $178

SONAL ARORA MD

Pulmonary Disease

3,480

$1.26M

467
323 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

51%
prescriptions for brand name drugs

Avg: 57%

$363
Average prescription price

Avg: $178

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank